Thursday, November 14, 2013

Just A Little More Complete Information -- On Various Pieces Of Propecia®/Proscar® Litigation -- From The Merck Q3 2013 SEC Form 10-Q


My early morning entry referred only to the federal MDL -- I'll toss up this update, as a new post, to give a sense of scale, here (there are only about one-fifth as many of these cases, as there are of the Fosamax® ONJ or Femur ones), and to include the state court proceedings. Only 20 cases allege cancers of any kind.

Here is the bit -- from page 21 of the Form 10-Q:

. . . . As of September 30, 2013, approximately 1,130 lawsuits involving a total of approximately 1,380 plaintiffs (in some instances spouses are joined as plaintiffs in the suits) who allege that they have experienced persistent sexual side effects following cessation of treatment with Propecia® and/or Proscar® have been filed against Merck. . . .

Approximately 20 of the plaintiffs also allege that Propecia or Proscar has caused or can cause prostate cancer or male breast cancer. The lawsuits have been filed in various federal courts and in state court in New Jersey. The federal lawsuits have been consolidated for pretrial purposes in a federal MDL before Judge John Gleeson of the Eastern District of New York. The matters pending in state court in New Jersey have been consolidated before Judge Jessica Mayer in Middlesex County. The Company intends to defend against these lawsuits. . . .


There -- now you know.

No comments: